KRTL BioTech

JP Morgan downgraded by KBW: 'Estimates cannot support current valuation'

JP Morgan downgraded by KBW: 'Estimates cannot support current valuation'

J.P. Morgan stock is up more than 37 percent this year, but analysts at Keefe Bruyette & Woods don't expect a repeat in 2020.